In particular, GPR18 mRNA levels can be prognostic among HPV(+)HNSCC patients, for which CD20 protein, MS4A1 and TIL-B levels were not prognostic at all. The gene discussed is GPR18; the disease is head and neck squamous cell carcinoma.